Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DESCOVY
- Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
- Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"
- Project Engage: Oral PrEP Acceptability
- The Women TAF-FTC Benchmark Study
- Pre-Exposure Prophylaxis for Transgender Women in the US and South America
- Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Have Sex With Men and Are at High Risk for HIV-1 Infection (MK-8591-024)
- Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
- Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia
- Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
- Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals
- A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP
- Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir Alafenamide
- RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP
- ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy
- The Cellular Pharmacology of F-TAF in Dried Blood Spots
- Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
- Bone Health in Aging HIV Infected Women
Clinical trials list
click for details